Cargando…
In vitro selection of Giardia duodenalis for Albendazole resistance identifies a β-tubulin mutation at amino acid E198K
Benzimidazole-2-carbamate (BZ) compounds, including Albendazole (Alb), are one of just two drug classes approved to treat the gastrointestinal protist Giardia duodenalis. Benzimidazoles bind to the tubulin dimer interface overlapping the colchicine binding site (CBS) of β-tubulin, thereby inhibiting...
Autores principales: | Emery-Corbin, Samantha J., Su, Qiao, Tichkule, Swapnil, Baker, Louise, Lacey, Ernest, Jex, Aaron R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267433/ https://www.ncbi.nlm.nih.gov/pubmed/34237690 http://dx.doi.org/10.1016/j.ijpddr.2021.05.003 |
Ejemplares similares
-
An antioxidant response is involved in resistance of Giardia duodenalis to albendazole
por: Argüello-García, Raúl, et al.
Publicado: (2015) -
Giardia duodenalis: Flavohemoglobin is involved in drug biotransformation and resistance to albendazole
por: Pech-Santiago, Edar O., et al.
Publicado: (2022) -
Differential protein expression and post-translational modifications in metronidazole-resistant Giardia duodenalis
por: Emery, Samantha J, et al.
Publicado: (2018) -
Data from a proteomic baseline study of Assemblage A in Giardia duodenalis
por: Emery, Samantha J., et al.
Publicado: (2015) -
Induction of virulence factors in Giardia duodenalis independent of host attachment
por: Emery, Samantha J., et al.
Publicado: (2016)